Oral Dispersible Tablet BE study USFDA submission [Regulatives / Guidelines]

posted by jag009  – NJ, 2018-04-13 23:23 (2640 d 15:53 ago) – Posting: # 18680
Views: 2,948

Hi,

❝ Till now , FDA has not issued the general invivo BE study recommendation to conduct the ODT


I did a bunch of them a few years back but ours were NDAs (505b2s, ODTs vs reg tablets). Tablet on tongue, subject can't chew but can "suck" (you know, the small movement of your tongue like when you swallow something) on the tablet. After 10 or 30 seconds (don't remember details) check mouth. Once everything is disappear, then we give water...

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,676 registered users;
49 visitors (0 registered, 49 guests [including 19 identified bots]).
Forum time: 15:17 CEST (Europe/Vienna)

Many people tend to look at programming styles and languages like religions:
if you belong to one, you cannot belong to others.
But this analogy is another fallacy.    Niklaus Wirth

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5